当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:66.34亿  总市值:70.53亿
流通股本:20.99亿   总股本:22.32亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.48亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益217777.98万元,未分配利润-43698.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产302996.01万元,负债85218.03万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,664,997,338.491,099,501,266.79551,255,672.122,440,732,030.17
营业总成本1,463,760,914.56977,868,310.54493,551,043.762,218,794,751.25
其他经营收益
营业利润265,253,964.82151,873,392.5769,069,634.07284,852,984.63
利润总额269,333,326152,089,011.4968,950,223.62283,692,120.46
净利润247,923,573.93137,424,012.9861,931,584.62242,540,034.93
每股收益
其他综合收益-639,692.29-159,250.63-40,526.17476,998.7
综合收益总额247,283,881.64137,264,762.3561,891,058.45243,017,033.63
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,149,038,353.7988,789,329.67946,591,300.71877,194,205.18
非流动资产:
非流动资产合计1,880,921,737.961,910,814,912.151,932,059,699.731,947,918,407.46
资产总计3,029,960,091.662,899,604,241.822,878,651,000.442,825,112,612.64
流动负债:
流动负债合计825,780,524.56803,842,424.56891,911,303.84823,033,579.93
非流动负债:
非流动负债合计26,399,808.8528,287,214.9428,446,043.5229,226,752.77
负债合计852,180,333.41832,129,639.5920,357,347.36852,260,332.7
所有者权益(或股东权益):
归属于母公司股东权益合计2,157,141,926.532,047,939,272.391,934,459,343.331,950,697,287.55
股东权益合计2,177,779,758.252,067,474,602.321,958,293,653.081,972,852,279.94
负债和股东权益合计3,029,960,091.662,899,604,241.822,878,651,000.442,825,112,612.64
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,936,541,711.791,261,295,248.11657,540,118.812,903,133,022.93
经营活动现金流出小计1,628,276,851.381,106,080,469.58551,065,624.662,492,197,219.82
经营活动产生的现金流量净额308,264,860.41155,214,778.53106,474,494.15410,935,803.11
投资活动产生的现金流量:
投资活动现金流入小计979,014,562.57708,336,463.16263,561,086.0436,696,852.8
投资活动现金流出小计1,307,839,226.981,023,318,605.54376,511,825.9695,560,805.14
投资活动产生的现金流量净额-328,824,664.41-314,982,142.38-112,950,739.92-58,863,952.34
筹资活动产生的现金流量:
筹资活动现金流入小计70,000,00070,000,00070,000,000218,213,750
筹资活动现金流出小计90,260,190.1588,725,853.2682,605,612.77801,456,448.33
筹资活动产生的现金流量净额-20,260,190.15-18,725,853.26-12,605,612.77-583,242,698.33
汇率变动对现金及现金等价物的影响-968,043.41-266,848.95-90,972.85939,419.49
现金及现金等价物净增加额-41,788,037.56-178,760,066.06-19,172,831.39-230,231,428.07
期末现金及现金等价物余额438,984,652.89302,012,624.39461,608,103.49480,772,690.45
补充资料:
现金及现金等价物的净增加额--178,760,066.06--230,231,428.07
最新报告期:2025-11-16
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
天风证券杨松0.110.130.142025-11-16
天风证券杨松0.110.130.142025-10-08
TOP↑